TXN vs. BMY
TXN (Texas Instruments Incorporated) and BMY (Bristol-Myers Squibb Company) are both stocks. TXN operates in Semiconductors (Technology), while BMY operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, TXN returned 20.39%/yr vs 1.00%/yr for BMY. At a 0.28 correlation, their price movements are largely independent.
Performance
TXN vs. BMY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TXN achieves a 75.59% return, which is significantly higher than BMY's 8.27% return. Over the past 10 years, TXN has outperformed BMY with an annualized return of 20.39%, while BMY has yielded a comparatively lower 1.00% annualized return.
TXN
- 1D
- 1.35%
- 1M
- -2.29%
- YTD
- 75.59%
- 6M
- 69.78%
- 1Y
- 58.75%
- 3Y*
- 22.83%
- 5Y*
- 12.97%
- 10Y*
- 20.39%
BMY
- 1D
- 0.40%
- 1M
- 0.63%
- YTD
- 8.27%
- 6M
- 11.43%
- 1Y
- 20.57%
- 3Y*
- 0.45%
- 5Y*
- 0.73%
- 10Y*
- 1.00%
TXN vs. BMY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
TXN Texas Instruments Incorporated | 75.59% | -4.47% | 13.14% | 6.41% | -9.86% | 17.53% | 31.70% | 39.56% | -7.17% | 46.75% |
BMY Bristol-Myers Squibb Company | 8.27% | 0.11% | 15.81% | -26.14% | 18.98% | 2.88% | 0.41% | 27.74% | -12.90% | 7.71% |
Correlation
The correlation between TXN and BMY is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.16 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.15 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.22 |
Correlation (All Time) Calculated using the full available price history since Jun 1, 1972 | 0.28 |
The correlation between TXN and BMY shifts across timeframes, from 0.15 (5 years) to 0.28 (all time), reflecting how their relationship changes across market environments.
Fundamentals
TXN:
$275.22B
BMY:
$116.75B
TXN:
$5.88
BMY:
$3.57
TXN:
51.24
BMY:
16.02
TXN:
14.91
BMY:
2.40
TXN:
16.40
BMY:
5.82
TXN:
$18.44B
BMY:
$48.48B
TXN:
$10.57B
BMY:
$33.33B
TXN:
$8.21B
BMY:
$13.34B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TXN vs. BMY — Risk / Return Rank
TXN
BMY
TXN vs. BMY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Texas Instruments Incorporated (TXN) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TXN | BMY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.70 | ||
| Sortino ratioReturn per unit of downside risk | +0.99 | ||
| Omega ratioGain probability vs. loss probability | 1.30 | 1.14 | +0.16 |
| Calmar ratioReturn relative to maximum drawdown | 1.87 | 1.53 | +0.34 |
| Martin ratioReturn relative to average drawdown | 3.90 | 3.32 | +0.58 |
Loading charts...
Drawdowns
TXN vs. BMY - Drawdown Comparison
The maximum TXN drawdown since its inception was -85.81%, which is greater than BMY's maximum drawdown of -72.03%. Use the drawdown chart below to compare losses from any high point for TXN and BMY.
Loading charts...
Drawdown Indicators
| TXN | BMY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -85.81% | -72.03% | -13.78% |
Max Drawdown (1Y)Largest decline over 1 year | -29.57% | -12.05% | -17.52% |
Max Drawdown (3Y)Largest decline over 3 years | -33.41% | -36.85% | +3.44% |
Max Drawdown (5Y)Largest decline over 5 years | -33.41% | -47.67% | +14.26% |
Max Drawdown (10Y)Largest decline over 10 years | -33.41% | -47.67% | +14.26% |
Current DrawdownCurrent decline from peak | -7.32% | -17.79% | +10.47% |
Average DrawdownAverage peak-to-trough decline | -34.78% | -22.38% | -12.40% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.17% | 6.34% | +7.83% |
Volatility
TXN vs. BMY - Volatility Comparison
Texas Instruments Incorporated (TXN) has a higher volatility of 14.23% compared to Bristol-Myers Squibb Company (BMY) at 8.22%. This indicates that TXN's price experiences larger fluctuations and is considered to be riskier than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TXN | BMY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.23% | 8.22% | +6.01% |
Volatility (6M)Calculated over the trailing 6-month period | 31.44% | 18.18% | +13.26% |
Volatility (1Y)Calculated over the trailing 1-year period | 40.13% | 27.08% | +13.05% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 32.42% | 24.02% | +8.40% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 31.17% | 25.29% | +5.88% |
Dividends
TXN vs. BMY - Dividend Comparison
TXN's dividend yield for the trailing twelve months is around 1.87%, less than BMY's 4.38% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BMY Bristol-Myers Squibb Company | 4.38% | 4.60% | 4.24% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% |
TXN Texas Instruments Incorporated | 1.87% | 3.17% | 2.81% | 2.94% | 2.84% | 2.23% | 2.27% | 2.50% | 2.78% | 2.03% | 2.25% | 2.55% |
Financials
TXN vs. BMY - Financials Comparison
This section allows you to compare key financial metrics between Texas Instruments Incorporated and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TXN vs. BMY - Profitability Comparison
TXN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Texas Instruments Incorporated reported a gross profit of 2.80B and revenue of 4.83B. Therefore, the gross margin over that period was 58.0%.
BMY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported a gross profit of 8.07B and revenue of 11.49B. Therefore, the gross margin over that period was 70.2%.
TXN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Texas Instruments Incorporated reported an operating income of 1.81B and revenue of 4.83B, resulting in an operating margin of 37.5%.
BMY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported an operating income of 3.27B and revenue of 11.49B, resulting in an operating margin of 28.5%.
TXN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Texas Instruments Incorporated reported a net income of 1.55B and revenue of 4.83B, resulting in a net margin of 32.0%.
BMY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported a net income of 2.68B and revenue of 11.49B, resulting in a net margin of 23.3%.
Frequently Asked Questions
TXN and BMY have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TXN has higher volatility (14.23%) compared to BMY (8.22%). In terms of maximum drawdown, TXN dropped -85.81% vs BMY's -72.03%.
TXN currently has the higher Sharpe Ratio (1.38 vs 0.68), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TXN and BMY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer